At both 6 months and 12 months follow-up, the rivaroxaban group was found to have more of these events than the apixaban group. Credit: Getty Images. In patients with atrial fibrillation and valvular ...

Choice of direct oral anticoagulant (DOAC) mattered for clinical outcomes among adults with atrial fibrillation (Afib), a study based on U.S. insurance claims found. Apixaban (Eliquis) users had ...

Initiators of rivaroxaban or warfarin vs apixaban have significantly higher rates of major hemorrhage. HealthDay News — For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators ...

For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban. Data remain inconclusive regarding ...

In everyday practice, patients with atrial fibrillation or flutter who are newly started on apixaban (Eliquis; Bristol-Myers Squibb) have lower ischemic and bleeding risks compared with those started ...

Anticoagulants, like NOACs and warfarin, are prescribed to people with NVAF to reduce their risk of stroke. In the 2019 update of the AHA/ACC/HRS Guidelines for the Management of Patients with Atrial ...

RARITAN, NJ, Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved XARELTO® to reduce the risk of stroke and systemic embolism in patients with ...

NEW ORLEANS, March 18, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a new real-world study, which found newly diagnosed patients with ...

Findings address a known evidence gap and add to the clinical evidence base from randomised controlled trials and network meta-analyses to directly compare direct oral anticoagulants for stroke ...

Please provide your email address to receive an email when new articles are posted on . Among older adults with atrial fibrillation, apixaban was linked to lower rates of adverse events across all ...